Recombinant multi-species CCL4/MIP-1 beta protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CCL4/MIP-1 beta protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is a mitogen-inducible monokine and is one of the major HIV-suppressive factors produced by CD8+ T-cells. The encoded protein is secreted and has chemokinetic and inflammatory functions. [provided by RefSeq, Dec 2012]
The Alternative Names of target: ACT2,AT744.1,C-C motif chemokine 4,CCL4,G-26,G-26 T-lymphocyte-secreted protein,HC21,LAG-1,LAG1,Lymphocyte activation gene 1 protein (LAG-1),MIP-1 beta,MIP-1-beta,MIP-1-beta(1-69),MIP1B,MIP1B1,Macrophage inflammatory protein 1-beta (MIP-1-beta),PAT 744,Protein H400,SCYA2,SCYA4,SIS-gamma,Small-inducible cytokine A4,T-cell activation protein 2 (ACT-2)

Target products collectionGo to CCL4/MIP-1 beta products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-SE0071-Ag-1/ GM-Tg-hg-SE0071-Ag-2 Human CCL4/MIP-1 beta protein Human
GM-Tg-rg-SE0071-Ag-1/ GM-Tg-rg-SE0071-Ag-2 Rat CCL4/MIP-1 beta protein Rat
GM-Tg-mg-SE0071-Ag-1/ GM-Tg-mg-SE0071-Ag-2 Mouse CCL4/MIP-1 beta protein Mouse
GM-Tg-cynog-SE0071-Ag-1/ GM-Tg-cynog-SE0071-Ag-2 Cynomolgus/Rhesus macaque CCL4/MIP-1 beta protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-SE0071-Ag-1/ GM-Tg-felg-SE0071-Ag-2 Feline CCL4/MIP-1 beta protein Feline
GM-Tg-cang-SE0071-Ag-1/ GM-Tg-cang-SE0071-Ag-2 Canine CCL4/MIP-1 beta protein Canine
GM-Tg-bovg-SE0071-Ag-1/ GM-Tg-bovg-SE0071-Ag-2 Bovine CCL4/MIP-1 beta protein Bovine
GM-Tg-equg-SE0071-Ag-1/ GM-Tg-equg-SE0071-Ag-2 Equine CCL4/MIP-1 beta protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-SE0071-Ag-1/ GM-Tg-hg-SE0071-Ag-2; GM-Tg-rg-SE0071-Ag-1/ GM-Tg-rg-SE0071-Ag-2;
GM-Tg-mg-SE0071-Ag-1/ GM-Tg-mg-SE0071-Ag-2; GM-Tg-cynog-SE0071-Ag-1/ GM-Tg-cynog-SE0071-Ag-2;
GM-Tg-felg-SE0071-Ag-1/ GM-Tg-felg-SE0071-Ag-2; GM-Tg-cang-SE0071-Ag-1/ GM-Tg-cang-SE0071-Ag-2;
GM-Tg-bovg-SE0071-Ag-1/ GM-Tg-bovg-SE0071-Ag-2; GM-Tg-equg-SE0071-Ag-1/ GM-Tg-equg-SE0071-Ag-2
Products Name CCL4/MIP-1 beta protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name CCL4/MIP-1 beta
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CCL4/MIP-1 beta protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.